help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peiris, A. N.
Right arrow Articles by Kissebah, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peiris, A. N.
Right arrow Articles by Kissebah, A. H.

Journal of Clinical Endocrinology & Metabolism, Vol 68, 715-720, Copyright © 1989 by Endocrine Society


ARTICLES

The relative contributions of hepatic and peripheral tissues to insulin resistance in hyperandrogenic women

AN Peiris, EJ Aiman, WD Drucker and AH Kissebah
Clinical Research Center, Medical College of Wisconsin, Milwaukee 53226.

Insulin resistance is associated with hyperandrogenic states. To determine the mechanisms by which androgen excess can affect insulin action, we studied insulin sensitivity in five nonobese hyperandrogenic women and six normal women. After oral glucose administration, the hyperandrogenic women had higher serum insulin concentrations than the normal women (P = 0.05). The mean cumulative peripheral serum insulin response in the hyperandrogenic women [79.6 +/- 30.8 (+/- SD) nmol/L.300 min] was significantly greater than that in the normal women (46.6 +/- 15.1 nmol/L.300 min; P less than 0.05). In the basal state and during hyperinsulinemic (20 mU/min.m2) euglycemic clamp studies serum insulin levels were similar in the two groups. Basal and insulin- mediated suppressions of hepatic glucose production determined from [3- 3H]glucose specific activity were similar in the two groups. Peripheral glucose utilization was markedly diminished in the hyperandrogenic women compared to that in the normal women (27.8 +/- 6.7 vs 48.9 +/- 12.8 mumol/min.kg fat-free mass; P less than 0.01). We conclude that the insulin resistance in nonobese hyperandrogenic women is due to peripheral, but not hepatic, resistance to the action of insulin. This marked peripheral insulin resistance may result from the effects of hyperandrogenemia on skeletal muscle fiber morphology and metabolism.


This article has been cited by other articles:


Home page
HypertensionHome page
G. Schillaci, M. Pirro, G. Pucci, M. R. Mannarino, F. Gemelli, D. Siepi, G. Vaudo, and E. Mannarino
Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women
Hypertension, May 1, 2006; 47(5): 881 - 886.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Iglseder, P. Cip, L. Malaimare, G. Ladurner, and B. Paulweber
The Metabolic Syndrome Is a Stronger Risk Factor for Early Carotid Atherosclerosis in Women Than in Men
Stroke, June 1, 2005; 36(6): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, C. Kouli, K. Alexandraki, and G. Spina
Failure of Mathematical Indices to Accurately Assess Insulin Resistance in Lean, Overweight, or Obese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1273 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. Vrbikova, B. Bendlova, M. Hill, M. Vankova, K. Vondra, and L. Starka
Insulin Sensitivity and {beta}-Cell Function in Women With Polycystic Ovary Syndrome
Diabetes Care, July 1, 2002; 25(7): 1217 - 1222.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Ek, P. Arner, M. Ryden, C. Holm, A. Thorne, J. Hoffstedt, and H. Wahrenberg
A Unique Defect in the Regulation of Visceral Fat Cell Lipolysis in the Polycystic Ovary Syndrome as an Early Link to Insulin Resistance
Diabetes, February 1, 2002; 51(2): 484 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Diamanti-Kandarakis, G. Spina, C. Kouli, and I. Migdalis
Increased Endothelin-1 Levels in Women with Polycystic Ovary Syndrome and the Beneficial Effect of Metformin Therapy
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4666 - 4673.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Gennarelli, J. Holte, L. Berglund, C. Berne, M. Massobrio, and H. Lithell
Prediction models for insulin resistance in the polycystic ovary syndrome
Hum. Reprod., October 1, 2000; 15(10): 2098 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. J. Marsden, A. P. Murdoch, and R. Taylor
Adipocyte insulin action in hypogonadotrophic hypogonadism
Hum. Reprod., August 1, 2000; 15(8): 1672 - 1678.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Niklasson, P. Daneryd, P. Lonnroth, and A. Holmang
Effects of exercise on insulin distribution and action in testosterone-treated oophorectomized female rats
J Appl Physiol, June 1, 2000; 88(6): 2116 - 2122.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, and J. S. Tapanainen
Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome
Hum. Reprod., June 1, 2000; 15(6): 1266 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Jaquet, J. Leger, D. Chevenne, P. Czernichow, and C. Levy-Marchal
Intrauterine Growth Retardation Predisposes to Insulin Resistance But Not to Hyperandrogenism in Young Women
J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3945 - 3949.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
A. Cagnacci, A.M. Paoletti, S. Arangino, G.B. Melis, and A. Volpe
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
Hum. Reprod., April 1, 1999; 14(4): 893 - 897.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Ek, P. Arner, A. Bergqvist, K. Carlstrom, and H. Wahrenberg
Impaired Adipocyte Lipolysis in Nonobese Women with the Polycystic Ovary Syndrome: A Possible Link to Insulin Resistance?
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1147 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Andersson, L.-A. Mattsson, L. Hahn, L. Lapidus, G. Holm, B.-A. Bengtsson, and P. Bjorntorp
Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Franks
Polycystic Ovary Syndrome
N. Engl. J. Med., September 28, 1995; 333(13): 853 - 861.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society